Showing results (121-130 of 179) with videos related to

Sort By:
Pageof 18
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1989
Verapamil interacts in vitro with alpha 2-adrenoceptors but does not modify alpha 2-receptivity in vivoM Galinier, J M Senard, P Valet, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1986
[Importance of standardization in the biological monitoring of anti-vitamin K therapy]F Forestier, B Boneu, G Potron, et al.
Joint Bone Spine|February 23, 2002
Myeloma and monoclonal gammopathy of uncertain significance associated with acquired von Willebrand's syndrome. Seven new cases with a literature reviewV Lamboley, Laurent Zabraniecki, P Sie, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1997
Long-term persistence of low-molecular-weight material with anti-factor Xa activity contributes to anticoagulant and antithrombotic effects after subcutaneous injection of CY 216 in the rabbitV Peyrou, J C Lormeau, J P Hérault, et al.
Circulation|June 22, 2000
Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humansY Cadroy, J P Bossavy, C Thalamas, et al.
Thrombosis and Haemostasis|December 29, 1984
Exercise-induced platelet activation in myocardial infarction survivors with normal coronary arteriogramP Douste-Blazy, P Sié, B Boneu, et al.
Fundamental & Clinical Pharmacology|January 1, 1990
Pharmacodynamics of CY 216 in healthy volunteers: inter-individual variationsM Rostin, J L Montastruc, G Houin, et al.
Thrombosis and Haemostasis|November 1, 1995
A comparative study of the anticoagulant and anti-thrombotic effects of unfractionated heparin and a low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosisA Diquélou, D Dupouy, R Cariou, et al.
Metabolism: Clinical and Experimental|October 1, 1989
Plasminogen activator inhibitor in plasma is related to testosterone in menP Caron, A Bennet, R Camare, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 14, 1999
Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosisJ P Bossavy, K S Sakariassen, K Rübsamen, et al.
Pageof 18